Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results 

Go back to Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results 
(NASDAQ: EPRX) Delayed: 8.42 +0.40 (4.99%)
Previous Close $8.02    52 Week High
Open $8.14    52 Week Low
Day High $8.49    P/E N/A 
Day Low $8.11    EPS
Volume 492,925